JINS HOLDINGS Inc. (JNDOF)
USD 22.75
(0.0%)
USD 22.75
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 73.26 Billion JPY | 9.51% |
| 2022 | 66.9 Billion JPY | 4.7% |
| 2021 | 63.89 Billion JPY | 6.04% |
| 2020 | 60.25 Billion JPY | -2.64% |
| 2019 | 61.89 Billion JPY | 12.8% |
| 2018 | 54.87 Billion JPY | 8.76% |
| 2017 | 50.45 Billion JPY | 9.23% |
| 2016 | 46.18 Billion JPY | 13.49% |
| 2015 | 40.69 Billion JPY | 12.58% |
| 2014 | 36.15 Billion JPY | -1.1% |
| 2013 | 36.55 Billion JPY | 61.65% |
| 2012 | 22.61 Billion JPY | 55.16% |
| 2011 | 14.57 Billion JPY | 37.45% |
| 2010 | 10.6 Billion JPY | 42.64% |
| 2009 | 7.43 Billion JPY | 19.47% |
| 2008 | 6.22 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 21.14 Billion JPY | 6.51% |
| 2024 Q1 | 18.16 Billion JPY | -7.8% |
| 2024 Q2 | 19.85 Billion JPY | 9.28% |
| 2023 Q3 | 19 Billion JPY | 8.57% |
| 2023 FY | 73.26 Billion JPY | 9.51% |
| 2023 Q4 | 19.7 Billion JPY | 3.66% |
| 2023 Q1 | 17.05 Billion JPY | 0.39% |
| 2023 Q2 | 17.5 Billion JPY | 2.66% |
| 2022 Q1 | 15.27 Billion JPY | -5.46% |
| 2022 FY | 66.9 Billion JPY | 4.7% |
| 2022 Q4 | 16.98 Billion JPY | -1.32% |
| 2022 Q3 | 17.21 Billion JPY | -1.25% |
| 2022 Q2 | 17.42 Billion JPY | 14.1% |
| 2021 Q3 | 16.09 Billion JPY | -4.35% |
| 2021 Q4 | 16.15 Billion JPY | 0.37% |
| 2021 Q1 | 14.81 Billion JPY | -19.68% |
| 2021 Q2 | 16.83 Billion JPY | 13.62% |
| 2021 FY | 63.89 Billion JPY | 6.04% |
| 2020 Q3 | 10.3 Billion JPY | -37.88% |
| 2020 Q1 | 14.92 Billion JPY | -11.53% |
| 2020 Q2 | 16.58 Billion JPY | 11.1% |
| 2020 Q4 | 18.44 Billion JPY | 79.0% |
| 2020 FY | 60.25 Billion JPY | -2.64% |
| 2019 FY | 61.89 Billion JPY | 12.8% |
| 2019 Q3 | 16.56 Billion JPY | 10.81% |
| 2019 Q1 | 13.5 Billion JPY | -10.08% |
| 2019 Q2 | 14.94 Billion JPY | 10.68% |
| 2019 Q4 | 16.87 Billion JPY | 1.86% |
| 2018 Q4 | 15.02 Billion JPY | 3.17% |
| 2018 Q1 | 11.69 Billion JPY | -12.17% |
| 2018 Q2 | 13.59 Billion JPY | 16.28% |
| 2018 Q3 | 14.55 Billion JPY | 7.05% |
| 2018 FY | 54.87 Billion JPY | 8.76% |
| 2017 FY | 50.45 Billion JPY | 9.23% |
| 2017 Q4 | 13.31 Billion JPY | -0.01% |
| 2017 Q3 | 13.31 Billion JPY | 4.97% |
| 2017 Q2 | 12.68 Billion JPY | 13.92% |
| 2017 Q1 | 11.13 Billion JPY | -11.42% |
| 2016 FY | 46.18 Billion JPY | 13.49% |
| 2016 Q4 | 12.57 Billion JPY | 3.95% |
| 2016 Q3 | 12.09 Billion JPY | 4.45% |
| 2016 Q2 | 11.57 Billion JPY | 16.35% |
| 2016 Q1 | 9.95 Billion JPY | -14.15% |
| 2015 Q1 | 8.14 Billion JPY | -8.42% |
| 2015 Q4 | 11.58 Billion JPY | 1.99% |
| 2015 Q3 | 11.36 Billion JPY | 18.38% |
| 2015 Q2 | 9.59 Billion JPY | 17.85% |
| 2015 FY | 40.69 Billion JPY | 12.58% |
| 2014 Q4 | 8.89 Billion JPY | -7.57% |
| 2014 FY | 36.15 Billion JPY | -1.1% |
| 2014 Q3 | 9.62 Billion JPY | 1.69% |
| 2014 Q2 | 9.46 Billion JPY | 15.84% |
| 2014 Q1 | 8.16 Billion JPY | -15.88% |
| 2013 Q4 | 9.71 Billion JPY | 5.76% |
| 2013 Q3 | 9.18 Billion JPY | -6.89% |
| 2013 FY | 36.55 Billion JPY | 61.65% |
| 2013 Q1 | 7.79 Billion JPY | 3.82% |
| 2013 Q2 | 9.86 Billion JPY | 26.43% |
| 2012 Q3 | 5.61 Billion JPY | 6.38% |
| 2012 Q4 | 7.51 Billion JPY | 33.82% |
| 2012 FY | 22.61 Billion JPY | 55.16% |
| 2012 Q1 | 4.2 Billion JPY | 3.35% |
| 2012 Q2 | 5.27 Billion JPY | 25.37% |
| 2011 Q4 | 4.07 Billion JPY | 8.55% |
| 2011 Q2 | 3.76 Billion JPY | 26.45% |
| 2011 Q3 | 3.75 Billion JPY | -0.44% |
| 2011 Q1 | 2.98 Billion JPY | 6.49% |
| 2011 FY | 14.57 Billion JPY | 37.45% |
| 2010 Q3 | 2.8 Billion JPY | -0.16% |
| 2010 FY | 10.6 Billion JPY | 42.64% |
| 2010 Q1 | 2.18 Billion JPY | 6.21% |
| 2010 Q4 | 2.79 Billion JPY | -0.3% |
| 2010 Q2 | 2.81 Billion JPY | 28.68% |
| 2009 Q3 | 1.84 Billion JPY | -8.77% |
| 2009 Q1 | 1.51 Billion JPY | 0.0% |
| 2009 Q4 | 2.05 Billion JPY | 11.78% |
| 2009 Q2 | 2.01 Billion JPY | 32.91% |
| 2009 FY | 7.43 Billion JPY | 19.47% |
| 2008 FY | 6.22 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -2295516.383% |
| Ansell Limited | 1.61 Billion USD | -4424.424% |
| Ansell Limited | 1.61 Billion USD | -4424.424% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -39577.768% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -54247428.785% |
| Psykey, Inc. | 419.29 Thousand USD | -17472872.747% |
| ConvaTec Group Plc | 2.19 Billion USD | -3239.265% |
| ConvaTec Group Plc | 2.14 Billion USD | -3319.716% |
| Encision Inc. | 6.58 Million USD | -1112340.217% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -4014530.738% |
| LifePoint, Inc. | -18.5 Thousand USD | 396021721.622% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -1075255.937% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -9490055.44% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -7428668.429% |
| Reflect Scientific, Inc. | 1.08 Million USD | -6782636.536% |
| SmileDirectClub, Inc. | 470.74 Million USD | -15463.482% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -3814.493% |
| SheerVision, Inc. | 3.49 Million USD | -2093511.861% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -5284781.85% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -9832766.501% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -70254879.239% |